Log in

SCAL Stem Cell Authority, Ltd. OTC · China

Stem Cell Authority (SCAL) news

Stem Cell Authority, Ltd. is a public biotech or pharmaceutical company listed on OTC under the ticker SCAL, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Stem Cell Authority news

We have not published a story on Stem Cell Authority yet. When there is news, it will appear here.

Questions about Stem Cell Authority

What is the ticker symbol of Stem Cell Authority?

Stem Cell Authority, Ltd. trades under the ticker SCAL on OTC.

Where is Stem Cell Authority listed?

Stem Cell Authority, Ltd. is listed on OTC.

Which country or territory is Stem Cell Authority listed under?

Our directory records Stem Cell Authority, Ltd. under China.

What does Stem Cell Authority do?

Our directory classifies Stem Cell Authority, Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Stem Cell Authority?

The ISIN recorded for Stem Cell Authority, Ltd. is US85857C1080.

Does aibio.space cover Stem Cell Authority?

aibio.space lists Stem Cell Authority, Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Stem Cell Authority?

Companies in our directory listed in the same country and business area as Stem Cell Authority: Boji Medical Technology Co., Xiamen Amoytop Biotech Co., Beijing SL Pharmaceutical Co., Anhui Huaheng Biotechnology Co., Hangzhou Tigermed Consulting Co., Fujian Haixi Pharmaceuticals Co..

Investor discussion: Stem Cell Authority

Members talk about Stem Cell Authority (SCAL). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:SCAL on TradingView.

Listing details

Stem Cell Authority, Ltd. is a public biotech or pharmaceutical company listed on OTC under the ticker SCAL, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Stem Cell Authority, Ltd.
Ticker
SCAL
Listing
OTC
Country or territory
China
Business scope
Biotechnology
ISIN
US85857C1080
Last quote in directory
2026-10-09
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.